Longevity Biomedical (Longevity Biomedical) Receivables Turnover : 0.00 (As of . 20)

View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Longevity Biomedical's Revenue for the six months ended in . 20 was $0.00 Mil. Longevity Biomedical's average Accounts Receivable for the six months ended in . 20 was $0.00 Mil.

Longevity Biomedical Receivables Turnover Historical Data

The historical data trend for Longevity Biomedical's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Receivables Turnover Chart

Longevity Biomedical Annual Data

Trend

Receivables Turnover

Longevity Biomedical Semi-Annual Data

Receivables Turnover

Competitive Comparison of Longevity Biomedical's Receivables Turnover

For the Biotechnology subindustry, Longevity Biomedical's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longevity Biomedical's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Receivables Turnover falls into.

Longevity Biomedical Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Longevity Biomedical's Receivables Turnover for the fiscal year that ended in . 20 is calculated as

	Receivables Turnover (A: . 20 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: . 20 )	/ (	(Accounts Receivable (A: . 20 )	+	Accounts Receivable (A: . 20 ))	/	count )
=		/ (	(	+	)	/	1 )
=		/	0
=	N/A

Longevity Biomedical's Receivables Turnover for the quarter that ended in . 20 is calculated as

	Receivables Turnover (Q: . 20 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: . 20 )	/ (	(Accounts Receivable (Q: . 20 )	+	Accounts Receivable (Q: . 20 ))	/	count )
=		/ (	(	+	)	/	1 )
=		/	0
=	N/A

Longevity Biomedical (NAS:LBIO) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Longevity Biomedical Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Biomedical (Longevity Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011

Website

https://www.longevitybiomedical.com

Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines